372 results on '"Manzo, Ciro"'
Search Results
2. Chat generative pre-trained transformer (ChatGPT): potential implications for rheumatology practice
3. Comprehensive geriatric assessment and palliative care.
4. Comment on: Immune checkpoint inhibitor-mediated polymyalgia rheumatica versus primary polymyalgia rheumatica: comparison of disease characteristics and treatment requirement
5. The VEXAS syndrome from rheumatology perspective: genomic DNA sequencing as available blueprint for diagnosing rheumatic diseases with overlapping haematological or dermatological findings
6. Questions as regards the recognition of elderly-onset primary Sjögren's syndrome: Where we are and where we would rather be
7. Presence of subclinical giant cell arteritis in patients with morning stiffness of duration less than 45 minutes at the time of diagnosis of polymyalgia rheumatica
8. The CITIMERIVA Study: CITIcoline plus MEmantina plus RIVAstigmine in Older Patients Affected with Alzheimer’s Disease
9. Early referral of patients with suspected polymyalgia rheumatica: An active involvement of the out-of-hospital public rheumatologist is needed
10. Polymyalgia rheumatica and polymyalgia-like syndromes as adverse events following immunisation with COVID-19 vaccines: a 15 months update
11. New-Onset Rheumatic Immune-Mediated Inflammatory Diseases Following SARS-CoV-2 Vaccinations until May 2023: A Systematic Review
12. Why would immuno- and endocrino-senescence, age-related changes in the gut microbiota, and susceptibility to infection favour polymyalgia rheumatica over seronegative elderly-onset rheumatoid arthritis?
13. Spatio-temporal analysis of prodelta dynamics by means of new satellite generation: the case of Po river by Landsat-8 data
14. Long-term glucocorticoid treatment in patients with polymyalgia rheumatica: can we just move a step forward? Comments on “Long-term glucocorticoid treatment and high relapse rate remain unresolved issues in the real-life management of polymyalgia rheumatica: a systematic literature review and meta-analysis”
15. Mapping turbidity patterns in the Po river prodelta using multi-temporal Landsat 8 imagery
16. A case of anti‐neutrophil cytoplasmic antibody‐associated vasculitis masquerading as Sjögren syndrome.
17. Delirium and modified-release prednisone in an elderly woman with rheumatoid arthritis
18. Neuropsychiatric clinical manifestations in elderly patients treated with hydroxychloroquine: a review article
19. Absence of Long-Lasting Morning Stiffness at the Time of Diagnosis as Paraneoplastic Warning in Patients with Polymyalgia Rheumatica (PMR): Data from Italian Single-Center Study
20. E057 A systematic review of new rheumatic immune-mediated inflammatory diseases (R-IMID) following SARS-CoV-2 vaccinations
21. Does a steroid dementia syndrome really exist? A brief narrative review of what the literature highlights about the relationship between glucocorticoids and cognition
22. Psychomotor Agitation Following Treatment with Hydroxychloroquine
23. Assessment of land cover changes in Lampedusa Island (Italy) using Landsat TM and OLI data
24. Correction to: The CITIMERIVA Study: CITIcoline plus MEmantine plus RIVAstigmine in Older Patients Affected with Alzheimer’s Disease
25. Coastal Subsidence
26. Presence of subclinical giant cell arteritis in patients with morning stiffness of duration less than 45 minutes at the time of diagnosis of polymyalgia rheumatica.
27. Polymyalgia rheumatica and cancer: the surveillance duration and other points to ponder
28. Is the absence of prolonged morning stiffness at the time of diagnosis of polymyalgia rheumatica a paraneoplastic warning?
29. The management of patients with polymyalgia rheumatica: limitations to get it right
30. Oral isotretinoin and sacroiliitis: causal link or coincidence? Discussion points emerging from a case-based review
31. A journey inside the elderly-onset primary Sjögren’s syndrome, looking for useful tips for the geriatrician
32. Post-COVID-19 Condition and İts Recognition in Low- and Middle-income Countries: Working Notes from the United Kingdom Experience
33. Fever Correlation with Erythrocyte Sedimentation Rate (ESR) and C-Reactive Protein (CRP) Concentrations in Patients with Isolated Polymyalgia Rheumatica (PMR): A Retrospective Comparison Study between Hospital and Out-of-Hospital Local Registries
34. Polymyalgia rheumatica and polymyalgia-like syndromes as adverse events following COVID-19 vaccines: working notes from a narrative review of published literature
35. Fever at diagnosis as a confounding factor in patients with polymyalgia rheumatica. Messages from primary care. Comments on Betrains et al.
36. Implications of fever on erythrocyte sedimentation rate but not on C-reactive protein concentrations at the time of diagnosis of polymyalgia rheumatica. Comments on Betrains et al.
37. Fever interference on erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) concentrations in patients with isolated polymyalgia rheumatica (PMR). A retrospective comparison study between hospital and out-of-hospital local registries
38. McMaster Online Rating of Evidence (MORE)
39. Answer to Cadiou et al. “SARS-CoV-2, polymyalgia rheumatica and giant cell arteritis: COVID-19 vaccine shot as a trigger?”. Joint Bone Spine 2021;88:105282
40. Multidimensional prognostic index in hospitalized COVID-19 patients with dementia and its relationship with non-invasive ventilation failure
41. The Role of Tumor Necrosis Factor Alpha Antagonists (Anti TNF-α) in Personalized Treatment of Patients with Isolated Polymyalgia Rheumatica (PMR): Past and Possible Future Scenarios
42. Early diagnosis in patients with polymyalgia rheumatica: is a fast track clinic a viable solution? Comment on: “Fast track clinic for early diagnosis of polymyalgia rheumatica: Impact on symptom duration and prednisolone initiation” by Frølund et al. Joint Bone Spine 2021;88:105185
43. Messages from the history of polymyalgia rheumatica
44. Comment on: Risk of giant cell arteritis and polymyalgia rheumatica following COVID-19 vaccination: a global pharmacovigilance study
45. Feasibility and usefulness of a fast-track clinic for patients suspected of polymyalgia rheumatica: notes for a work schedule through a narrative review of published literature
46. Multidimensional prognostic index in hospitalized COVID-19 patients with dementia and its relationship with non-invasive ventilation failure
47. Remitting seronegative symmetrical synovitis with pitting edema and polymyalgia-like syndromes following cancer immunotherapy with checkpoint inhibitors: causal link, potential association or else?
48. Can SARS-CoV-2 trigger relapse of polymyalgia rheumatica?
49. Drug-induced lupus erythematosus associated with donepezil: a case report
50. Polymyalgia rheumatica as uncommon adverse event following immunization with COVID‐19 vaccine: A case report and review of literature
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.